Could you tell Bioanalysis Zone a little about your career to date and how you ended up in your current role?
The route to my current position has been a bit more circuitous than most. I initially obtained a PhD in Neuroscience from Dalhousie University in Halifax (Nova Scotia, Canada) and subsequently completed a Post Doc at Yale University (CT, USA), fully expecting to continue into an academic career. However, in early 2001, I was attracted to a small biotech firm in North Carolina that was developing a drug-screening platform for Huntington’s and Parkinson’s diseases. In 2004, I was hired by MDS Pharma as a Team Leader in their Ligand-binding and Cell-based Assay Department and subsequently became the Associate Director in 2005 and Scientific Director in 2008. In September 2010, I joined PharmaNet as Director of Immunochemistry and Cell Biology, overseeing the Princeton (NJ, USA) large molecule lab.